Medlab Clinical (Medlab Clinical) Price-to-Operating-Cash-Flow : (As of Jun. 09, 2024)

View and export this data going back to 2017. Start your Free Trial

What is Medlab Clinical Price-to-Operating-Cash-Flow?

As of today (2024-06-09), Medlab Clinical's share price is $15.75. Medlab Clinical's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was $-0.89. Hence, Medlab Clinical's Price-to-Operating-Cash-Flow Ratio for today is .

The historical rank and industry rank for Medlab Clinical's Price-to-Operating-Cash-Flow or its related term are showing as below:

MDBBF's Price-to-Operating-Cash-Flow is not ranked ^*
in the Biotechnology industry.
Industry Median: 25.29
* Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.

Medlab Clinical's Cash Flow from Operations per share for the six months ended in Dec. 2023 was $0.01. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was $-0.89.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 29.80% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was -36.00% per year.

During the past 8 years, Medlab Clinical's highest 3-Year average Operating Cash Flow per Share Growth Rate was 29.80% per year. The lowest was -337.00% per year. And the median was -24.10% per year.

Medlab Clinical Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Medlab Clinical's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medlab Clinical Price-to-Operating-Cash-Flow Chart

Medlab Clinical Annual Data

Trend

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Price-to-Operating-Cash-Flow

Get a 7-Day Free Trial

Medlab Clinical Semi-Annual Data
	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Price-to-Operating-Cash-Flow	Get a 7-Day Free Trial												-	-	-	-	-

Competitive Comparison of Medlab Clinical's Price-to-Operating-Cash-Flow

For the Biotechnology subindustry, Medlab Clinical's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Medlab Clinical's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Medlab Clinical's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Medlab Clinical's Price-to-Operating-Cash-Flow falls into.

Medlab Clinical Price-to-Operating-Cash-Flow Calculation

Medlab Clinical's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio	=	Share Price	/	Cash Flow from Operations per share (TTM)
	=	15.75	/	-0.885
	=

Medlab Clinical's Share Price of today is $15.75.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Medlab Clinical's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was $-0.89.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio

Market Cap

Cash Flow from Operations

Medlab Clinical Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Medlab Clinical's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

Medlab Clinical (Medlab Clinical) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Medlab Clinical Ltd (OTCPK:MDBBF) » Definitions » Price-to-Operating-Cash-Flow

Comparable Companies

Traded in Other Exchanges

N/A

Address

11 Lord Street, Unit 5, Botany, NSW, AUS, 2019

Website

https://www.medlab.co

Medlab Clinical Ltd is a medical research and development company. It is engaged in researching and formulating novel biotherapeutics to improve health outcomes in early to moderate stage chronic diseases such as chronic kidney disease, pre-diabetes, and obesity. Some of the company's nutraceutical products are Multibiotic, Mg Optima Relax, NRGBiotic, NanoCelle D3, SB 5B and others. The principal segments of the group are Nutraceutical which includes the sale of nutraceutical products; and Pharmaceutical research. It generates the majority of the revenue from the sale of nutraceutical products. The business operations of the firm are carried out from Australia.